Milestone Pharmaceuticals
MIST
MIST
29 hedge funds and large institutions have $116M invested in Milestone Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
6
Reduced
8
Closed
2
Calls
$1.77M
Puts
$273K
Net Calls
+$1.49M
Net Calls Change
+$325K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$8.11M |
2 |
LPC
2
Lion Point Capital
New York
|
$5.63M |
3 |
BL
3
Bleichroeder LP
New York
|
$3.04M |
4 |
ACP
4
Acuta Capital Partners
Redwood City,
California
|
$2.81M |
5 |
5
Millennium Management
New York
|
$8.07M |
Top Sellers
1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$8.19M |
2 |
BFM
2
Boothbay Fund Management
New York
|
$815K |
3 |
3
Barclays
London,
United Kingdom
|
$1.3M |
4 |
PP
4
PDT Partners
New York
|
$0 |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$21K |